We are excited to release the 

GRAPPA  2022 Annual Meeting Newsletter





GRAPPA Social Media Pages 1.pdf


Introducing CAPES: A New, Multifaceted Education Series for Patients and Physicians!

GRAPPA has partnered with SPARTAN, SAA, and NPF to develop and present a series of webinars and podcasts for physicians and patients, to educate them on spondyloarthritis (SpA) and psoriatic arthritis (PsA).

As a collective group of nonprofit organizations committed to improving research and understanding of our respective diseases, we’re excited to launch this unique, collaborative project, and we hope you’ll join us! 

REGISTER NOW FOR upcoming modules and topics and access archived presentations. https://capes.performedia.com/


September 2022 – Module 2: Pain and Fatigue

Managing chronic pain and fatigue in patients with psoriatic arthritis (PsA) and spondyloarthritis (SpA) can be challenging for providers. Hear rheumatologists Dr. Philip Mease (Director, Rheumatology Research Swedish Medical Center/Providence St. Joseph Health) and Dr. Ernest Choy (Cardiff University School of Medicine), and patients Melissa Leeolou and Minionette “Mini” Wilson discuss causes, symptoms, risks, and the latest in managing chronic pain and fatigue successfully.

This is the second of three CME episodes in CAPES (Clinician and Patient Education Series) presented by NPF, GRAPPA, SPARTAN, and SAA.

This program is supported by an educational grant from Pfizer Inc.


Designation of Credit

The National Psoriasis Foundation designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.





The GRAPPA Annual Meeting and Trainee Symposium 2022 in Brooklyn, New York was a great success.

 With over 205 people attending in person, 186 people joining virtually, and 27 countries represented, we had great involve

ment and participation.

 Thank you to all who contributed to this event.

 Recordings of plenary sessions and workshops are available here for on-demand viewing.

Simply click on the session you would like to view and select the Watch Now button.

Remember to visit the online poster tour!







Congratulations to our Pilot Research Grant Awardees 2022


In collaboration with Medscape, GRAPPA is proud to share:

The Psoriasis to Psoriatic Arthritis Continuum: A Case-Based Discussionis.

This activity is intended for rheumatologists, dermatologists, and primary care physicians.

The goal of this activity is that learners will be better able to manage patients with psoriasis, including assessment and treatment continuation.

Upon completion of this activity, participants will:

  • Demonstrate improved performance associated with
    • Evaluating plaque psoriasis (PsO) severity using objective and subjective assessments
    • Assessing joint involvement in patients with PsO
    • Selecting evidence-based treatments for psoriatic disease




Congratulations to the following Trainees for being selected to present their abstracts at the GRAPPA Annual Meeting and Trainee Symposium 2022.

David Simon Advanced neural networks for classification of MRI in psoriatic arthritis, seronegative, and seropositive rheumatoid arthritis.
Celia Michielsens Treat-to-target dose reduction and withdrawal strategy of TNF inhibitors in Psoriatic Arthritis and Axial Spondyloarthritis: a randomized controlled non-inferiority trial.
Gizem Ayan Development of a Biologic Treatment Decision Algorithm According to Peripheral T-Helper Cell Profile Using Cytokine Secretion Assay: A proof of concept study.
Andre Ribeiro Challenges in the Management of Psoriatic Arthritis in Latin America: a systematic review.
Devis Benfaremo Screening for the Early Identification of Psoriatic Arthritis with Axial Involvement (axPsA) in A Cohort of Italian Patients Affected by Psoriasis (ATTRACT): Preliminary Results of a Cross-Sectional Study.
Selinde Snoeckhenkemans Early achievement of minimal disease activity in psoriatic arthritis is associated with long-term improvements in quality of life.
Lara Ceolin Correlation among gender, genital psoriasis and sexual function in patients with psoriasis and psoriatic arthritis.
Francesco Bellinato Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies.
Mariana dos Santos Pereira Evaluation of liver fibrosis using transient elastography in patients with psoriasis treated with methotrexate.
Keith Colaco Derivation and Internal Validation of a Disease-specific Cardiovascular Risk Prediction Model for Patients with Psoriatic Arthritis and Psoriasis.
Alla Ishchenko Comorbidities In Early Psoriatic Arthritis: Prospective METAPSA Cohort.
Filippo Fagni Multispectral optoacoustic tomography for the non-invasive metabolic profiling of inflammation in synovitis and enthesitis.
Jenna Yousif An investigator-initiated trial of a polymeric emulsion of halobetasol propionate and tazarotene in the treatment of palmoplantar psoriasis.
Jonathan Koptyev Incidence of COVID-19 hospitalization in patients with psoriasis taking systemic immunomodulators.
Thanos Vassilopoulos Biologic and Targeted Synthetic Therapies in Psoriatic Arthritis and the Risk of Opportunistic Infections.
Hanna Johnsson Immunoglobulins Are Upregulated In Psoriatic Arthritis Skin Lesions But Not In Psoriasis Skin Lesions.
Marlene Sousa What does worsening in DAPSA disease activity categories mean for patients with psoriatic arthritis? An analysis of 222 patients.
Janne Bolt Increased neutrophil frequency in lymph nodes
of patients with psoriatic arthritis.
Mayara Barros Prevalence of scalp psoriasis and its possible association with joint involvement: a retrospective study of 1218 cases.
Augustina Alfaror Adherence to GRAPPA 2015 Treatment Recommendations According to the Presences of Comorbidities in Patients with Psoriatic Arthritis.
Henriette Käding Clinical and imaging-based characterization of a prospective cohort of patients with axial psoriatic arthritis (axial PsA). GESPIC-axial PsA: Results of an interim analysis. (ONLINE POSTER ONLY)
Julia Schally Validation of the Disease Activity Index for PSoriatic Arthritis (DAPSA) with a quick quantitative C-reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis (PsA): A prospective multicenter cross-sectional study. (ONLINE POSTER ONLY)


Introducing GRAPPA's New Executive Director

We are happy to announce the hiring of GRAPPA’s new executive director, Judi Pickell, due to Sharon Andrews’ retirement at the end of this year. Judi is a skilled nonprofit organization manager with years of professional executive director experience. The executive committee is impressed with her related background in non-profit work and believe that her experience and energy will guide GRAPPA as this organization continues to grow.

Judi lives in Utah. She started training virtually with Sharon this week. We are confident the transition will be smooth. Her new email address is: [email protected].

Finally, on behalf of all the GRAPPA family, we would like to thank Sharon for her incredible years of service to the GRAPPA organisation which are now sadly coming to an end. We wish Sharon every happiness and success in her retirement.


Thank you to all who attended the recent GRAPPA Adjacent to ACR meeting. The on-demand video can be found here https://youtu.be/2qSxSagvgxw. Click here for the agenda.

Save the Dates:
GRAPPA Adjacent to AAD 2022

GRAPPA Adjacent to AAD will be held on Sunday, March 27, 2022, from 5:30 - 7:20 pm EST in Boston. An in person meeting is currently planned
Registration and an agenda are forthcoming.

Hold the date: GRAPPA 2022 Annual Meeting & Trainee Symposium, Brooklyn, New York, July 14-16, 2022

2021 Virtual Annual Meeting & Trainee Symposium

The on-demand videos of all sessions from the 2021 Annual Meeting & Trainee Symposium are now available on this website. Find the links under the "Events" tab and "Annual Meeting and Trainee Symposium." 

COVID-19 Vaccines and Psoriatic Disease

Do you have questions about the new COVID-19 vaccines for people with psoriasis and psoriatic arthritis? Click here to read a joint guidance statement from IFPA and GRAPPA.

GRAPPA COVID-19 Guidance Statement

This guidance was prepared by rheumatologists, dermatologists and patient members of GRAPPA to provide guidance to persons with psoriasis and/or psoriatic arthritis during the current COVID-19 pandemic, in particular to those taking immunosuppressant medicines. Click here to read entire statement.

GRAPPA’s “A Patient’s Guide to Treatments for Psoriatic Arthritis”

This guide is now available free for download. Written in lay language, it explains current treatments for psoriatic disease. Health care professionals are encouraged to provide it to their patients. The guide was written by members of GRAPPA’s patient research partner team, with support from GRAPPA’s treatment recommendations group. Printing instructions are supplied in a separate pdf. To download, please click on this icon:

GRAPPA Mission

GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) is organized exclusively for non-profit, educational, and scientific purposes, specifically to facilitate sharing of information related to psoriasis and psoriatic arthritis, networking among different medical disciplines that see psoriasis and psoriatic arthritis patients, and to enhance research, diagnosis and treatment of psoriasis and psoriatic arthritis.

The GRAPPA app!

The GRAPPA app, available in Apple and Android formats, is free to download from the Apple store and the Google Play Store. Designed to be used by physicians, this app includes various calculators. Languages include: English, French, Italian, Spanish, Portuguese (standard and Brazilian), Russian, German, Arabic, Chinese (simplified, Hong Kong and Taiwan), Japanese, Hebrew and Swedish.

The app is free to download to all, both GRAPPA members and non-members. Here are the links:


Google Play and the Google Play logo are trademarks of Google LLC.